Interleukin-1 in the Response of Follicular Helper and Follicular Regulatory T Cells.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 27 07 2018
accepted: 29 01 2019
entrez: 16 3 2019
pubmed: 16 3 2019
medline: 12 9 2020
Statut: epublish

Résumé

The role of interleukin-1 in the regulation of humoral responses is poorly documented, in contrast to its role in inflammation. Recent findings suggest there is an interleukin-1 axis in the follicular T cell control of B cell responses, involving interleukin-1 receptors (IL-1R1 and IL-1R2) and receptor antagonists (IL-1Ra). Here, we revisit the literature on this topic and conclude that targeting the interleukin-1 pathway should be a valuable therapeutic approach in many diseases involving excessive production of (auto)antibodies, such as autoimmune diseases or allergy.

Identifiants

pubmed: 30873158
doi: 10.3389/fimmu.2019.00250
pmc: PMC6402473
doi:

Substances chimiques

Interleukin 1 Receptor Antagonist Protein 0
Interleukin-1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

250

Références

J Immunol. 1999 May 15;162(10):6141-7
pubmed: 10229857
Clin Immunol. 2000 May;95(2):117-23
pubmed: 10779405
Annu Rev Immunol. 2000;18:621-63
pubmed: 10837071
J Immunol. 2001 Jul 1;167(1):90-7
pubmed: 11418636
Immunology. 2001 Dec;104(4):402-9
pubmed: 11899425
J Neuroimmunol. 2003 Mar;136(1-2):140-8
pubmed: 12620653
Ann Rheum Dis. 2005 Apr;64(4):630-3
pubmed: 15345502
Lupus. 2004;13(8):605-6
pubmed: 15462491
Nature. 1992 Apr 30;356(6372):768-74
pubmed: 1574116
J Immunol. 2005 Aug 1;175(3):1974-82
pubmed: 16034142
J Immunol. 2005 Aug 1;175(3):2018-25
pubmed: 16034147
Lancet. 2005 Aug 13-19;366(9485):579-82
pubmed: 16099294
Nat Med. 2006 Jan;12(1):138-43
pubmed: 16341241
Eur Cytokine Netw. 2006 Jun;17(2):109-16
pubmed: 16840029
J Immunol. 2006 Aug 15;177(4):2167-74
pubmed: 16887976
PLoS Med. 2006 Aug;3(8):e297
pubmed: 16942393
J Immunol. 2007 Apr 15;178(8):5271-6
pubmed: 17404311
J Immunol. 2007 Aug 1;179(3):1423-6
pubmed: 17641006
N Engl J Med. 2008 Feb 14;358(7):676-88
pubmed: 18272891
Cytokine. 2008 Apr;42(1):48-54
pubmed: 18346907
Arthritis Rheum. 2008 Jul;58(7):1947-57
pubmed: 18576312
J Immunol. 2008 Aug 1;181(3):1767-79
pubmed: 18641314
J Immunol. 1991 May 1;146(9):2908-14
pubmed: 1901890
Autoimmunity. 2010 Jun;43(4):255-63
pubmed: 19845478
Nat Rev Immunol. 2010 Feb;10(2):89-102
pubmed: 20081871
Sci Signal. 2010 Jan 19;3(105):cm1
pubmed: 20086235
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Allergol Int. 2010 Jun;59(2):125-35
pubmed: 20414049
Neurol Clin. 2011 May;29(2):257-78
pubmed: 21439440
Eur J Immunol. 2011 May;41(5):1203-17
pubmed: 21523780
Nat Med. 2011 Jul 24;17(8):983-8
pubmed: 21785430
Nat Med. 2011 Jul 24;17(8):975-82
pubmed: 21785433
Nat Rev Immunol. 2011 Jul 25;11(8):519-31
pubmed: 21785456
J Immunol. 2011 Nov 1;187(9):4553-60
pubmed: 21984700
Cytokine Growth Factor Rev. 2011 Aug;22(4):189-95
pubmed: 22019906
Semin Immunol. 2011 Dec;23(6):424-30
pubmed: 22055883
J Clin Endocrinol Metab. 2012 Mar;97(3):943-50
pubmed: 22188745
Brain. 2012 Jun;135(Pt 6):1819-33
pubmed: 22561643
Mediators Inflamm. 2012;2012:416036
pubmed: 22745523
Nat Rev Drug Discov. 2012 Aug;11(8):633-52
pubmed: 22850787
J Immunol. 1990 Mar 15;144(6):2179-83
pubmed: 2313092
Brain Behav Immun. 2013 Aug;32:1-8
pubmed: 23195532
EMBO J. 1990 May;9(5):1503-10
pubmed: 2328723
PLoS One. 2013 Apr 29;8(4):e62426
pubmed: 23658628
Nat Rev Immunol. 2013 Jun;13(6):397-411
pubmed: 23702978
Int Immunopharmacol. 2013 Sep;17(1):116-22
pubmed: 23770281
Am J Respir Cell Mol Biol. 2013 Dec;49(6):989-98
pubmed: 23837489
Front Immunol. 2013 Jul 15;4:182
pubmed: 23874332
Mod Rheumatol. 2015;25(6):954-7
pubmed: 24252009
Arthritis Rheumatol. 2014 Jan;66(1):152-62
pubmed: 24449582
J Cell Sci. 2014 Jun 1;127(Pt 11):2383-90
pubmed: 24829146
J Biol Chem. 2014 Sep 26;289(39):26872-81
pubmed: 25096571
J Immunol. 1989 May 1;142(9):3129-33
pubmed: 2523425
Eur J Immunol. 2015 Jan;45(1):298-308
pubmed: 25263533
Immunity. 2014 Oct 16;41(4):529-42
pubmed: 25367570
Nat Rev Immunol. 2015 May;15(5):283-94
pubmed: 25882245
Nat Commun. 2016 Jan 28;7:10579
pubmed: 26818004
Endocr Res. 2016 Aug;41(3):185-92
pubmed: 26864865
J Allergy Clin Immunol. 2017 Jan;139(1):300-313.e7
pubmed: 27325434
Endocrinol Metab (Seoul). 2016 Sep;31(3):379-385
pubmed: 27586448
J Immunol. 2017 Jun 15;198(12):4553-4560
pubmed: 28583987
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6400-E6409
pubmed: 28698369
Neurosci Lett. 2017 Aug 24;656:169-176
pubmed: 28743581
Sci Immunol. 2017 Sep 8;2(15):null
pubmed: 28887367
Nat Immunol. 2017 Nov;18(11):1249-1260
pubmed: 28892471
J Allergy Clin Immunol. 2018 Oct;142(4):1144-1158.e8
pubmed: 29247716
Immunol Rev. 2018 Jan;281(1):233-247
pubmed: 29247989
Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S21-S40
pubmed: 29447987
Hum Immunol. 2018 Apr;79(4):228-232
pubmed: 29454070
J Immunol. 1987 Aug 1;139(3):800-4
pubmed: 2955051
J Immunol. 1987 Sep 1;139(5):1546-9
pubmed: 2957429
J Exp Med. 2018 Jun 4;215(6):1531-1542
pubmed: 29769249
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9604-9609
pubmed: 30158170
Front Immunol. 2018 Aug 24;9:1910
pubmed: 30197643
J Immunol. 1983 May;130(5):2191-4
pubmed: 6601146
J Neuroimmunol. 1995 Sep;61(2):241-5
pubmed: 7593560
J Neuroimmunol. 1998 Jan;81(1-2):76-81
pubmed: 9521608
Ann N Y Acad Sci. 1998 Sep 29;856:1-11
pubmed: 9917859

Auteurs

Paul-Gydéon Ritvo (PG)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.

David Klatzmann (D)

Sorbonne Université, INSERM, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH